Stephens & Co. Reiterates Overweight on Steris, Maintains $250 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Jacob Johnson reiterated an Overweight rating on Steris (NYSE:STE) and maintained a $250 price target.
February 09, 2024 | 6:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. analyst Jacob Johnson reiterated an Overweight rating on Steris and maintained a $250 price target.
The reiteration of an Overweight rating and the maintenance of a $250 price target by a reputable analyst could signal confidence in Steris's future performance, potentially influencing investor sentiment positively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100